Draganfly’s onsite demonstration to government representatives will consist of a live drone flight equipped with the Company’s Smart Vital system. Using existing drone camera systems, the Company’s Smart Vital system is able to survey, with voluntary consent, vital signs including heart rate, respiratory rate, temperature, and blood oxygen content (SpO2). The system does not register any personal data of the individual being screened.
On
Further, On
“We are thrilled to be participating in EDGE22,” said
“Draganfly is an innovator in robotic, sensors, AI, and UAV technologies. As the showcase and forum for advanced technologies supporting vital government missions, EDGE22@CES is delighted to feature Draganfly to the EDGE22 drone/UAV agenda,” said
EDGE, formerly CES Government, is produced by the
EDGE22 brings together technology and mission leaders from
To register for EDGE22, please click here.
About
For more information on
For additional investor information visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.nasdaq.com/market-activity/stocks/dpro or https://www.boerse-frankfurt.de/aktie/draganfly-inc.
Media Contact
Email: media@draganfly.com
Company Contact
Email: info@draganfly.com
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements include, but are not limited to, statements with respect to the Company’s participation in EDGE22. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in
Source:
2022 GlobeNewswire, Inc., source